Radiopharmaceuticals and contrast media

1-Methyl-4-phenylpyridinium (MPP+) induces neurotoxicity by inhibiting mitochondrial redox functions in the striatal synaptosomes. It is a potential neurotoxin and induces Parkinson&#8242s disease in animal models.

MS CAP GL45/DIN45 PTFE

Mse A-Ckn CD4-PACBLU 0.1 mg

Mse A-Ckn IgM-FITC 0.5 mg

Mse A-Hmn CD36-UNLB 0.1 mg

Mse A-Hmn CD95-APC 100 tests

Mse A-Hmn CD95-APC 25 tests

Mse A-Hmn IgD-AP 1.0 mL

Mse A-Hmn IgD-FITC 0.5 mg

Mse A-Hmn IgD-UNLB 0.5 mg

Mse A-Hmn IgG Fc-AP 1.0 mL

Mse A-Hmn IgG Fc-LE/AF 0.5 mg